Radionuclide evaluation of liver transplants

Area of Science:

• Nuclear Medicine
• Transplant Surgery
• Hepatology

Background:

• Orthotopic liver transplantation is a standard treatment for end-stage liver disease.
• The increasing number of liver transplant recipients necessitates nuclear medicine evaluations.
• Nuclear medicine plays a vital role in assessing post-transplant complications.

Purpose of the Study:

• To highlight the utility of radionuclide studies in evaluating orthotopic liver transplant recipients.
• To emphasize the role of 99mTc iminodiacetic acid (IDA) compounds in monitoring graft status.
• To discuss the application of these studies in the postoperative period.

Main Methods:

• Utilizing 99mTc iminodiacetic acid (IDA) compounds, especially 99mTc diisopropyl IDA (DISIDA), for hepatobiliary imaging.
• Focusing on radionuclide evaluations in the postoperative period.
• Employing serial imaging and clinical data correlation for diagnosis.

Main Results:

• 99mTc-IDA compounds are well-suited for monitoring structural and functional changes in liver grafts.
• Postoperative complications such as vascular/biliary issues, rejection, infections, and bile leaks alter hepatobiliary study results.
• Differentiating functional changes (rejection, infection) requires serial imaging and clinical correlation.

Conclusions:

• 99mTc-IDA scintigraphy is essential for evaluating liver transplant recipients, particularly postoperatively.
• Quantitative analyses of 99mTc-IDA and other agents like 99mTc-NGA can improve assessment of subtle liver function changes.
• Nuclear medicine imaging aids in the management of liver transplant patients by detecting and monitoring complications.